SPARCL1 DEREGULATED IN ENDOMETRIOSIS LESIONS

被引：1
|
作者：
Ferriani, R. A. [1 ]
Meola, J. [1 ]
Hidalgo, G. dos S. [1 ]
Rosa e Silva, J. C. [1 ]
Paz, C. C. P. [1 ]
机构：
[1] Univ Sao Paulo, Sao Paulo, Brazil
来源：
FERTILITY AND STERILITY | 2010年 / 94卷 / 04期
关键词：
D O I：
10.1016/j.fertnstert.2010.07.789
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [21] Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates
    Nunez-delMoral, Amaia
    Brocos-Mosquera, Iria
    Vialou, Vincent
    Callado, Luis F.
    Erdozain, Amaia M.
    NEUROSCIENCE, 2021, 467 : 91 - 109
  • [22] The inhibition of HeLa cells proliferation through SPARCL1 mediated by SPP1
    Zhang, Shengpeng
    Zhang, Fengge
    Feng, Limin
    CYTOTECHNOLOGY, 2021, 73 (01) : 71 - 78
  • [23] The inhibition of HeLa cells proliferation through SPARCL1 mediated by SPP1
    Shengpeng Zhang
    Fengge Zhang
    Limin Feng
    Cytotechnology, 2021, 73 : 71 - 78
  • [24] SPARCL1基因在肿瘤中的表达及作用
    赵书杰
    周栋
    国际肿瘤学杂志, 2016, 43 (09) : 673 - 675
  • [25] SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
    Zhang, Hai-Ping
    Wu, Jun
    Liu, Zhi-Feng
    Gao, Jing-Wen
    Li, Shu-Yu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [26] SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
    Zhang, Hai-Ping
    Wu, Jun
    Liu, Zhi-Feng
    Gao, Jing-Wen
    Li, Shu-Yu
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [27] Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression
    Hurley, Paula J.
    Hughes, Robert M.
    Simons, Brian W.
    Huang, Jessie
    Miller, Rebecca M.
    Shinder, Brian
    Haffner, Michael C.
    Esopi, David
    Kimura, Yasunori
    Jabbari, Javaneh
    Ross, Ashley E.
    Erho, Nicholas
    Vergara, Ismael A.
    Faraj, Sheila F.
    Davicioni, Elai
    Netto, George J.
    Yegnasubramanian, Srinivasan
    An, Steven S.
    Schaeffer, Edward M.
    CANCER RESEARCH, 2015, 75 (20) : 4322 - 4334
  • [28] Profile and clinical significance of SPARCL1 and its prognostic significance in breast cancer
    Xu, Xin-Yu
    Han, Ying-Wen
    Song, Yun-Xiao
    Zhou, Zhen-Yu
    Chen, Shu
    Liu, Yu-Wei
    Zhou, Ying
    Chen, Jie
    ONCOLOGY LETTERS, 2025, 29 (04)
  • [29] SPARCL1, a novel prognostic predictive factor for GI malignancies: A meta-analysis
    Hu, H.
    Cai, W.
    Ge, W.
    ANNALS OF ONCOLOGY, 2017, 28
  • [30] Autosomal dominant stromal corneal dystrophy associated with a SPARCL1 missense variant
    Braddock, Freddie L.
    Gardner, Jessica C.
    Bhattacharyya, Nihar
    Sanchez-Pintado, Beatriz
    Costa, Marcos
    Zarouchlioti, Christina
    Szabo, Anita
    Liskova, Petra
    Cheetham, Michael E.
    Young, Robert D.
    Thaung, Caroline
    Davidson, Alice E.
    Tuft, Stephen J.
    Hardcastle, Alison J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, : 1583 - 1589
12345